Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

Background: Serum neurofilament light chain (sNfL) is a promising biomarker to complement the decision-making process in multiple sclerosis (MS) patients. However, although sNfL levels are able to detect disease activity and to predict future disability, the growing evidence has not yet been transla...

Full description

Bibliographic Details
Main Authors: Sinah Engel, Maria Protopapa, Falk Steffen, Vakis Papanastasiou, Christoforos Nicolaou, Michalis Protopapas, Frauke Zipp, Stefan Bittner, Felix Luessi
Format: Article
Language:English
Published: SAGE Publishing 2021-04-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864211001977

Internet

https://doi.org/10.1177/17562864211001977

Similar Items